Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Increasing time costs and copayments for prescription drugs: an analysis of policy changes in a complex environment.

Domino ME, Martin BC, Wiley-Exley E, Richards S, Henson A, Carey TS, Sleath B.

Health Serv Res. 2011 Jun;46(3):900-19. doi: 10.1111/j.1475-6773.2010.01237.x. Epub 2011 Feb 9.

2.

Effect of Medicaid Policy Changes on Medication Adherence: Differences by Baseline Adherence.

Amin K, Farley JF, Maciejewski ML, Domino ME.

J Manag Care Spec Pharm. 2017 Mar;23(3):337-345. doi: 10.18553/jmcp.2017.23.3.337.

3.

Can increases in CHIP copayments reduce program expenditures on prescription drugs?

Sen B, Blackburn J, Morrisey M, Becker D, Kilgore M, Caldwell C, Menachemi N.

Medicare Medicaid Res Rev. 2014 May 20;4(2). pii: mmrr2014.004.02.a03. doi: 10.5600/mmrr2014-004-02-a03. eCollection 2014.

4.

Chronic Health Outcomes and Prescription Drug Copayments in Medicaid.

Kostova D, Fox J.

Med Care. 2017 May;55(5):520-527. doi: 10.1097/MLR.0000000000000700.

PMID:
28234755
5.

Effect on drug utilization and expenditures of a cost-share change from copayment to coinsurance.

Klepser DG, Huether JR, Handke LJ, Williams CE.

J Manag Care Pharm. 2007 Nov-Dec;13(9):765-77.

6.
7.

The effect of a Medicaid drug copayment program on the utilization and cost of prescription services.

Nelson AA Jr, Reeder CE, Dickson WM.

Med Care. 1984 Aug;22(8):724-36.

PMID:
6433121
8.

How effective are copayments in reducing expenditures for low-income adult Medicaid beneficiaries? Experience from the Oregon health plan.

Wallace NT, McConnell KJ, Gallia CA, Smith JA.

Health Serv Res. 2008 Apr;43(2):515-30. doi: 10.1111/j.1475-6773.2007.00824.x. Epub 2008 Jan 29.

9.

Who bears the burden of Medicaid drug copayment policies?

Stuart B, Zacker C.

Health Aff (Millwood). 1999 Mar-Apr;18(2):201-12.

10.

Impact of Medicaid copayments on patients with cancer: lessons for Medicaid expansion under health reform.

Subramanian S.

Med Care. 2011 Sep;49(9):842-7. doi: 10.1097/MLR.0b013e31821b34db.

PMID:
21577164
11.

Impact of a Medicaid copayment policy on prescription drug and health services utilization in a fee-for-service Medicaid population.

Hartung DM, Carlson MJ, Kraemer DF, Haxby DG, Ketchum KL, Greenlick MR.

Med Care. 2008 Jun;46(6):565-72. doi: 10.1097/MLR.0b013e3181734a77.

PMID:
18520310
12.
13.

Payment restrictions for prescription drugs under Medicaid. Effects on therapy, cost, and equity.

Soumerai SB, Avorn J, Ross-Degnan D, Gortmaker S.

N Engl J Med. 1987 Aug 27;317(9):550-6.

PMID:
3302713
14.

Unintended consequences of a Medicaid prescription copayment policy.

Lieberman DA, Polinski JM, Choudhry NK, Avorn J, Fischer MA.

Med Care. 2014 May;52(5):422-7. doi: 10.1097/MLR.0000000000000119.

PMID:
24686394
15.

Medication days' supply, adherence, wastage, and cost among chronic patients in Medicaid.

Taitel M, Fensterheim L, Kirkham H, Sekula R, Duncan I.

Medicare Medicaid Res Rev. 2012 Sep 19;2(3). pii: mmrr.002.03.a04. doi: 10.5600/mmrr.002.03.a04. eCollection 2012.

16.

Economic impacts of Medicaid in North Carolina.

Dumas C, Hall W, Garrett P.

N C Med J. 2008 Mar-Apr;69(2):78-87.

PMID:
18605153
18.

Effect of a medication copayment increase in veterans with schizophrenia.

Zeber JE, Grazier KL, Valenstein M, Blow FC, Lantz PM.

Am J Manag Care. 2007 Jun;13(6 Pt 2):335-46.

19.

Copayment for pharmaceutical services in a Medicaid program.

Nelson AA Jr, Quick MR.

Contemp Pharm Pract. 1980 Winter;3(1):37-42.

PMID:
10297666
20.

Association between drug insurance cost sharing strategies and outcomes in patients with chronic diseases: a systematic review.

Mann BS, Barnieh L, Tang K, Campbell DJ, Clement F, Hemmelgarn B, Tonelli M, Lorenzetti D, Manns BJ.

PLoS One. 2014 Mar 25;9(3):e89168. doi: 10.1371/journal.pone.0089168. eCollection 2014. Review.

Supplemental Content

Support Center